United Kingdom· GB-APID-23046711000001104
Topotecan 4mg/4ml concentrate for solution for infusion vials
A topotecan product containing topotecan, registered in United Kingdom by Teva UK Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Topotecan is registered in 15 of 19 countries.
Countries holding a registration under ATC L01CE01 (topotecan), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Topotecan · ATC L01CE01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of topotecan costs, country by country.
Normalised to the WHO defined daily dose (1 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Topotecan · price per daily dose (1 mg)
USD · FX 28 Sept 2026
- CH Switzerland$80.29
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Topotecan
- Manufacturer
- Teva UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01CE01
- ATC class
- Topotecan
- Defined daily dose
- 1 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5017007081012
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
348 interactions on record for topotecan.
Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Topotecan · interactions on record
348 records
- 31 severe
- 277 moderate
- 16 minor
- 24 info
Most severe, free to view
- CisplatinL01XA01severe
- CarboplatinL01XA02severe
- OxaliplatinL01XA03severe
- RolapitantA04AD14moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Topotecan in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandEvotopinBeecham Group plc.
- BelgiumHycamtin 0.25 mgSandoz Pharmaceuticals
- CzechiaHYCAMTINSandoz Pharmaceuticals d.d., Ljubljana
- SwedenHycamtin 0,25 mg Kapsel, hårdSandoz Pharmaceuticals d.d.
- IrelandHYCAMTIN 0.25 mg hard capsulesSandoz Pharmaceuticals d.d.
- NetherlandsHycamtin 0,25mg, Capsule, hardSandoz Pharmaceuticals d.d.
- PolandHycamtinSandoz Pharmaceuticals d.d.
- United StatesHYCAMTINNovartis Pharmaceuticals Corporation
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Topotecan Accord, Topotecan Ebewe
- Belgium · Topotecan Accord Healthcare
- Bulgaria · Топотекан Акорд
- Cyprus · Topotecan Accord, Topotecan Venus
- Czechia · Topotecan Accord
- Germany · Topotecan Accord, Topotecan Hexal
- Denmark · Topotecan "ebewe", Topotecan Accord
- Estonia · Topotecan Accord
- Spain · Topotecán Accord
- Finland · Topotecan Accord, Topotecan Ebewe
- France · Topotecane Accord
- Greece · Topocan, Topotecan Accord
- Croatia · Topotekan Alpha-Medical
- Hungary · Topotecan Accord
- Ireland · Topotecan Accord
- Iceland · Hycamtin, Potactasol
- Italy · Topotecan Ahcl
- Liechtenstein · Hycamtin, Hycamtin 4 Mg Powder For Concentrate For Solution For Infusion
- Lithuania · Topotecan Accord
- Luxembourg · Topotecan Accord Healthcare
- Latvia · Topotecan Ahcl
- Netherlands · Topotecan Accord, Topotecan Hikma
- Norway · Hycamtin, Potactasol
- Poland · Topotecanum Accord
- Portugal · Topotecano Accord, Topotecano Azevedos
- Romania · Topotecan Accord
- Sweden · Topotecan Accord, Topotecan Ebewe
- Slovenia · Topotekan Accord
- Slovakia · Topotecan Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e9188ef0-fbe9-4461-b649-e0c19de7dd62 GET /v1/drugs/e9188ef0-fbe9-4461-b649-e0c19de7dd62?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "23046711000001104",
"desc": "Topotecan 4mg/4ml concentrate for solution for infusion vials (Teva UK Ltd)",
"form": "Solution for infusion",
"vpid": "19627511000001104",
"source": "dmd",
"vtm_id": "777809000",
"strength": "1 mg",
"substance": "Topotecan",
"ingredient": "Topotecan hydrochloride",
"supplier_code": "3849901000001105"
}See everything about topotecan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.